Driehaus Capital Management LLC Bellus Health Inc. Transaction History

Driehaus Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$8.22 - $10.76 $40,064 - $52,444	-4,874 Reduced 1.31%	366,226 $3.01 Million
Q3 2022 Nov 14, 2022	BUY	$8.95 - $12.0 $3.32 Million - $4.45 Million	371,100 New	371,100 $3.92 Million
Q3 2020 Nov 16, 2020	SELL	$2.14 - $12.02 $711,618 - $4 Million	-332,532 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.88 - $11.15 $94,421 - $118,557	10,633 Added 3.3%	332,532 $3.42 Million
Q1 2020 May 15, 2020	BUY	$5.77 - $10.85 $230,217 - $432,904	39,899 Added 14.15%	321,899 $3.21 Million
Q3 2019 Nov 14, 2019	BUY	$6.24 - $8.84 $1.76 Million - $2.49 Million	282,000 New	282,000 $1.8 Million

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.